| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Revenue | $0 | -100.0% |
| R&D Expense | $56.1M | -11.5% |
| SG&A Expense | $28.7M | -21.4% |
| Operating Income | -$84.8M | -287.1% |
| Income Tax | $0 | — |
| Net Income | -$74.9M | -670.0% |
| EPS (Basic) | -$1.18 | -637.5% |
| EPS (Diluted) | -$1.18 | -637.5% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $197.5M | +239.3% |
| Current Assets | $357.5M | +43.0% |
| Total Assets | $366.3M | +40.5% |
| Current Liabilities | $13.0M | +18.1% |
| Total Liabilities | $17.3M | -2.3% |
| Stockholders' Equity | $349.0M | +43.6% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$60.1M | -2608.1% |
| Capital Expenditures | $314K | +12.9% |
| Investing Cash Flow | $30.7M | -4.7% |
| Financing Cash Flow | $168.7M | +6042.3% |
| Free Cash Flow | -$60.4M | -2319.0% |